Improved small molecule drug release fromin situforming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles

Unknown

(2016)   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Unknown

(2013)   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release

(2013) Marianne Parent et al.   JOURNAL OF CONTROLLED RELEASE

Controlled synergistic delivery of paclitaxel and heat from poly(β-amino ester)/iron oxide-based hydrogel nanocomposites

(2012) Samantha A. Meenach et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review

(2011) Susanne Fredenberg et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Inhibition of Osteoclast Differentiation and Bone Resorption byN-Methylpyrrolidone

(2011) Chafik Ghayor et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effect of Polymer Type on the Dynamics of Phase Inversion and Drug Release in Injectable In Situ Gelling Systems

(2011) Hui Liu et al.   JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION

N-Methyl Pyrrolidone as a Potent Bone Morphogenetic Protein Enhancer for Bone Tissue Regeneration

(2009) Blanca San Miguel et al.   TISSUE ENGINEERING PART A

Structure formation and characterization of injectable drug loaded biodegradable devices: In situ implants versus in situ microparticles

(2008) H. Kranz et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Controlled delivery of aspirin: Effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems

(2008) Yu Tang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Controlled drug delivery in tissue engineering

(2007) Marco Biondi et al.   ADVANCED DRUG DELIVERY REVIEWS